Make your money go further for just 25p per day

Coronavirus

AIM IHT
Company Insights

Novacyt reassures…to a degree

22/06/2021
Results from the diagnostics specialist offer some clarity, but are the shares cheap?

More on Coronavirus


Company Insights

Novacyt: never a dull moment but time for greater clarity

21/05/2021
AIM IHT
Company Insights

A good day for Covid testing companies

17/05/2021
AIM IHT
Company Insights

Novacyt: on these numbers, the cheapest stock on the market

29/01/2021
PREMIUM
Company Insights

A reasonably valued healthcare company, there must be a catch! (Updated)

18/11/2020
Company Insights

Vaccine countdown update: 17 Nov (2) - quality is worth the premium

17/11/2020
Company Insights

Vaccine countdown update: 17 Nov - wonderful updates from pandemic winners, but…

17/11/2020
AIM IHT
Company Insights

Vaccine countdown update: 12 Nov - apparent value here and probably a few traps

12/11/2020
Company Insights

​Coronavirus impact: 9 Nov – a renewable energy day

09/11/2020
AIM IHT
Company Insights

Coronavirus impact: 6 Nov - lowly rated developer is in good shape

06/11/2020
AIM IHT
Company Insights

Coronavirus impact: 5 Nov – Bonkers Bargains, data winner and plenty more

05/11/2020
AIM IHT
Company Insights

October 2020: AIM arrivals, departures, IHT qualifiers ...and another Covid tester

03/11/2020
Company Insights

Coronavirus impact: 30 Oct- digital security software business fills its coffers

30/10/2020
Company Insights

Coronavirus impact: 29 Oct - red flag report doesn’t bode well, but it’s not all gloom

29/10/2020
Company Insights

Coronavirus impact: 23 Oct - what’s Victoria’s Chairman up to now?

23/10/2020
AIM IHT
Company Insights

Coronavirus impact: 22 Oct - several terrific updates here

22/10/2020
AIM IHT
Company Insights

Coronavirus impact: 19 Oct - boohoo tumbles (again) but others impress

19/10/2020
Company Insights

Coronavirus impact: 16 Oct - the perils of being non-essential

16/10/2020
AIM IHT
Company Insights

Coronavirus impact: 15 Oct - not a negative to be seen

15/10/2020
Company Insights

Coronavirus impact: 14 Oct - horror shows and delights

14/10/2020
PREMIUM
Portfolio

US software stocks shine in lockdown

14/10/2020